Jaakkola, U <br/><br/>
Neuropeptide Y polymorphism significantly magnifies diabetes and cardiovascular disease risk in obesity: the Hoorn Study.  [electronic resource] 

 -  European journal of clinical nutrition  Jan 2009 
 - 150-2 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5640 
<br/><br/><label>Standard No.: </label>10.1038/sj.ejcn.1602964  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Blood Glucose--genetics<br/>Blood Pressure--genetics<br/>Body Mass Index<br/>Body Weight--genetics<br/>Cardiovascular Diseases--genetics<br/>Diabetes Mellitus--etiology<br/>Female<br/>Follow-Up Studies<br/>Glucose Tolerance Test<br/>Humans<br/>Male<br/>Neuropeptide Y--genetics<br/>Obesity--complications<br/>Polymorphism, Single Nucleotide<br/>Risk Factors